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Introduction
Kartagener’s syndrome was defined in 1933 as a
distinctive clinico-pathological entity character-
ized by a triad of signs: situs inversus, bronchiec-
tasis and paranasal sinusitis. The condition is a part
of the syndrome of primary ciliary dyskinesia,
where 50% of the patients have a situs inversus
totalis. In primary ciliary dyskinesia, inflammation
is not restricted to the ciliated conducting airways,
but also occurs in the alveolar space.1
Repetitive episodes of pleuritic chest pain are a
feature of patients with bronchiectasis and middle
lobe syndrome.2–4 Pleuritic chest pain can occur in
up to 21% of patients with bronchiectasis and 19% of
patients with middle lobe syndrome and character-
istically occurs in an area overlying a bronchiecta-
tic lobe.2,3 This presentation can be confused with
other conditions, such as pulmonary embolus.4
However, the natural history of pleuritic chest pain
and its response to analgesia in these conditions is
poorly described. We report a patient with Karta-
gener’s syndrome with intractable pleuritic chest
pain, in whom peripheral nerve stimulation with
subcutaneous electrodes led to a dramatic ther-
apeutic response.
Case report
A 37-year-old female was admitted for assessment
of intractable pleuritic chest pain. Kartagener’s
syndrome was diagnosed at age 13 years when she
presented with recurrent respiratory tract infec-
tions. The patient had pansinusitis, situs inversus,
bronchiectasis and primary infertility, but had
successfully conceived with the aid of in vitro
fertilisation. She had an appendicectomy at 15
years of age and a cholecystectomy at 34 years,
both left-sided. She had suffered from recurrent
respiratory tract infections and chronic pleuritic
left-sided chest pain since 31 years of age which
could not be controlled on combinations of non-
steroidal anti-inflammatory drugs and opiates. The
pain was constant and was located in the left
anterior chest wall, prevented full inspiration, and
was exacerbated by intercurrent respiratory tract
infections and cough. At the time of admission, the
patient was depressed and anxious because of the
pain, and felt that her pain was severely interfering
with her quality of life.
Physical examination revealed crackles at the
left base, wheeze and healed left-sided cholecys-
tectomy and appendicectomy incisions. Chest
radiograph and high resolution computerised tomo-
graphy of thorax showed dextrocardia and left
middle lobe (morphologically a right middle lobe)
bronchiectasis and atelectasis (Fig. 1). Fibreoptic
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bronchoscopy showed transposed bronchial anat-
omy with inflamed left middle and right lower lobes
containing purulent secretions. Bronchial washings
cultured Haemophilus influenzae, which was sensi-
tive to broad spectrum antibiotics. A pair of
temporary subcutaneous quatrode electrodes (Ad-
vanced Neuromodulation Systems, Texas, USA) was
inserted under anaesthesia with fentanyl 150mg,
propofol 30mg and midazolam 3mg intravenously.
Electrodes were inserted at the point of maximum
hyperalgesia, as determined by cotton wool and
pin-prick testing (midaxillary (T4;5) and midclavi-
cular areas (T6;7)). The patient experienced im-
mediate analgesia. Pulmonary function testing
demonstrated an immediate and sustained rise in
forced expiratory volume in 1 s (FEV1) from 1.3 to
2.12 l (63% increase) and forced vital capacity (FVC)
from 1.89 to 3.08 l (62% increase; Fig. 2). In view of
the clinical response, the temporary device was
removed 7 days after insertion and a set of
quatrode electrodes (ANS) were inserted and
connected to an internal power source (Genesis,
ANS) under general anaesthetic. Chest radiograph
showed improvement in the atelectatic changes in
the left middle lobe. She remained pain free after
the procedure, declined further analgesics, and
spirometry values have remained significantly im-
proved at 2 weeks and 2 months follow-up (Fig. 2).
Discussion
This phenotype of primary ciliary dyskinesia results
from axonemal abnormalities of respiratory cilia
and sperm flagella, mainly an absence of dynein
arms, and is inherited as an autosomal recessive
disorder.5 Diagnosis of primary ciliary dyskinesia is
clinical and is confirmed by studies of ciliary
motility and ultrastructure. Radiologically, the
disease progresses from bronchial wall thickening
to parenchymal changes including atelectasis,
consolidation, and bronchiectasis. There is a pre-
dilection for anatomic middle lobe abnormalities.
The radiological appearance and clinical state have
similarities to cystic fibrosis, although they are less
severe and less progressive. Pulmonary function
testing most commonly reveals mild airflow ob-
struction.6 Management is directed to microbial
suppression and clearing of retained secretions.
The natural history of intractable pleuritic chest
pain in primary ciliary dyskinesia is unknown.
Thoracic paravertebral block has been success-
fully used in the management of intractable
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Figure 1 Dextrocardia with left middle lobe bronchiec-
tasis.
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Figure 2 The rise in FEV1 and FVC is demonstrated after insertion of the temporary subcutaneous stimulator (TSS)
device which is sustained after its replacement with a permanent device (PSS) 30 days later.
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pleuritic chest pain.7 Electrical nerve stimulation is
a diagnostic procedure, which involves stimulation
of peripheral nerves by a needle electrode inserted
through the skin. The nerve stimulation does not
prevent pain but only alleviates pain as it occurs.
The procedure is used to treat chronic, intractable
pain conditions such as intractable angina.8 Nor-
mally, this lead is implanted in the epidural space
but this was relatively contraindicated in this
patient because of the risk of epidural abscess.
Electrical nerve stimulation is an accepted mod-
ality for assessing suitability for ongoing treatment
with an implanted nerve stimulator. The physician
should be able to determine whether the patient is
likely to derive a significant therapeutic benefit
from continuing use of an implanted nerve stimu-
lator within a trial period of one month. If pain is
effectively controlled by percutaneous stimulation,
implantation of electrodes is warranted.
Chronic chest pain is a common problem in
patients with bronchiectasis, cystic fibrosis, and
middle lobe syndrome. Analgesics may lead to
serious and difficult to manage side effects in these
patients.4,9 Few interventions have a significant
impact on quality of life or lung function in patients
with most pulmonary disorders. Although this
technique unmasked the patient’s true lung func-
tion, rather than improving a decline in lung
function, the clinical result was the same. This
procedure, used in a patient with Kartagener’s
syndrome and chronic pain due to left middle lobe
bronchiectasis, improved both lung function and
quality of life. The authors believe that the
technique should be considered as a therapeutic
option in patients with chronic pleuritic chest pain.
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